|
|
 | | | |
- close
- close
- close
- close
Benzinga
Apr 29
Comment
Midway through trading Monday, the Dow traded up 0.49 percent to 14,784.76 while the NASDAQ gained 0.84 percent to 3,306.75. The S&P also rose, surging 0.58 percent to 1,591.39.
Top Headline
Loews (NYSE: L) reported a 34% drop in its...
StreetInsider.com
Apr 29
Comment
* Conceptus, Inc. (Nasdaq: CPTS) has signed a definitive merger agreement with Bayer HealthCare LLC, Leverkusen, Germany.
With this acquisition, Bayer will be able to offer a complete range of short-term, long-term and permanent contraceptive...
Benzinga
Apr 29
Comment
Conceptus (NASDAQ: CPTS) soared 19.77% to $31.02 in the pre-market trading after Bayer AG agreed to acquire the company for about $1.1 billion.
SINA (NASDAQ: SINA) moved up 10.34% to $55.50 in the pre-market session after the company formed a...
Wall Street Journal
Apr 29
Comment
German chemicals and pharmaceuticals group Bayer said it would acquire California-based Conceptus to bolster its flagging contraceptives business in a deal that values the company at $1.1 billion.
Benzinga
Apr 29
Comment
Conceptus (NASDAQ: CPTS) announced today that Conceptus has signed a definitive merger agreement with Bayer HealthCare LLC, Leverkusen, Germany.
With this acquisition, Bayer will be able to offer a complete range of short-term, long-term and...
StreetInsider.com
Mar 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Summer+Street+Upgrades+Conceptus+%28CPTS%29+to+Buy/8161336.html for the full story.
TheStreet.com
Feb 6
Comment
WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes...
StreetInsider.com
Feb 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Conceptus%2C+Inc.+%28CPTS%29+Tops+Q4+EPS+by+6c%3B+Issues+FY13+Revs+Outlook/8061542.html for the full story.
Benzinga
Dec 20
Comment
Stifel Nicolaus initiated coverage on Conceptus (NASDAQ: CPTS) with a Buy rating and a $26 price target.
Stifel Nicolaus noted, "We asked doctor contacts about the biggest obstacles to greater Essure adoption. The two most frequently cited...
StreetInsider.com
Oct 23
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Conceptus%2C+Inc.+%28CPTS%29+Tops+Q3+EPS+by+2c%3B+Affirms+Outlook/7812408.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
